SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,186.74 |
| Enterprise Value ($M) | 2,591.33 |
| Book Value ($M) | 727.68 |
| Book Value / Share | 15.13 |
| Price / Book | 3.01 |
| NCAV ($M) | -271.55 |
| NCAV / Share | -5.65 |
| Price / NCAV | -8.05 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.12 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.27 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.61 |
| Current Ratio | 3.43 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 545.95 |
| Assets | 1,545.18 |
| Liabilities | 817.50 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Federated Hermes, Inc. | 4.52 | -33.85 | |
| 13G/A | Vanguard Group Inc | 5.88 | 7.36 | |
| 13G/A | Zhang Jack Y. | 26.20 | 2.48 | |
| 13G/A | BlackRock Inc. | 12.60 | -14.23 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 67,047 | 300,596 | 22.30 | |
| 35,752 | 365,487 | 9.78 | |
| 36,766 | 257,661 | 14.27 | |
| 68,021 | 327,578 | 20.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALXO – ALX Oncology Holdings Inc. | AMGN – Amgen Inc. |
| AMLX – Amylyx Pharmaceuticals, Inc. | AMRX – Amneal Pharmaceuticals, Inc. |
| ANAB – AnaptysBio, Inc. |
Financial data and stock pages provided by
Fintel.io